Tag: Life Sciences
Cell and gene therapy startup ElevateBio raises $170 million
While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed. Cambridge-based ElevateBio, for instance, revealed a $170 million Series B funding on Monday, with participation from new investors The Invus…
Read More
Oxford scientists develop new coronavirus test that provides results in just 30 minutes
Scientists at the University of Oxford have developed a new coronavirus test that produces results around three times faster than the current fastest testing methods, and that requires only relatively simple technical instrumentation. In addition to these benefits, the researchers behind the test’s development say that it could even help…
Read More
Despite Trump’s claims, Google isn’t building the coronavirus screening site — and it’s not ready
In a press conference at the White House, President Trump today announced that 1,700 Google engineers were working on a Coronavirus screening site. That site was supposedly the first step in a new screening process that would lead people from figuring out if their symptoms warranted more testing to the…
Read More
As national COVID-19 cases top 1000, insurers waive treatment fees and U.S. preps stimulus
The number of COVID-19 cases in the U.S. crossed 1,000 on Tuesday as President Donald Trump met with the nation’s largest insurers and members of his cabinet to discuss how to pay for treatment and lessen the financial blow of the disease’s spread. With the nation’s healthcare apparatus beginning to…
Read More
Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop, and scale treatments to the COVID-19 epidemic. The COVID-19 Therapeutics Accelerator will evaluate new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term,…
Read More
Karius raises $165 million for its liquid biopsy technology identifying diseases in a drop of blood
“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled in $165 million in new funding. While the new money may have been raised under the looming threat of Covid 19,…
Read More